Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

symptoms

Celgene building

NICE rejects Celgene’s Vidaza for leukaemia

Final draft guidance cites ‘high degree of uncertainty’ over clinical efficacy

Celgene building

Celgene takes aim at cancer innovation with new US research consortium

Academic tie-up aims to develop new therapeutics and diagnostics

- PMLiVE

Things can only get better

How can pharma get closer to its dream scenario where patients adhere to their medicines? The answer could lay in understanding behaviours, engaging HCPs and... making medicine fun

- PMLiVE

Digitally yours: How to build effective relationships in virtual space

Can you imagine life without mobile and digital access? Certainly not. But is the healthcare sector making the most of the opportunities?

- PMLiVE

Diabetes UK uses Lego to address diabetes myths

Teams up with Brickabetes to document the highs and lows of living with diabetes

- PMLiVE

Ogilvy & Mather’s ‘Breathless choir’ wins top pharma prize at Lions Health

FCB’s ‘Project literacy’ and DAVID’s ‘Manboobs’ also take home Grand Prix awards

- PMLiVE

EMA recruits patient voices for its management board

Continues its drive to embed patients' values within drug assessment

The death of deference

We are entering an age when authority matters less

- PMLiVE

Boehringer Ingelheim launches ‘gamified’ COPD initiative

Programme aims to encourage and reward disease management

- PMLiVE

Technology: the missing link in true patient engagement?

Approximately 50% of patients do not take their medication as prescribed. This comes at a huge financial cost, and results in suboptimal patient outcomes. There is a wealth of research...

- PMLiVE

Leveraging HCP transparency insights to drive future customer investments

EFPIA’s disclosure requirements present an opportunity to assess strategy and effectiveness

EU flag

Second Remicade biosimilar given green light in Europe

Samsung Bioepis’ Flixabi provides another lower-cost treatment option

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links